{ "@context": "https://schema.org", "@type": "Article", "url": "https://undersrvd.com/opportunities/persistent-symptom-diagnostic-safety-net-primary-care", "slug": "persistent-symptom-diagnostic-safety-net-primary-care", "title": "Persistent-Symptom Diagnostic Safety-Net for Primary Care", "categories": [ "HealthTech", "NHS", "Health & Social Care", "MedTech", "Data & Analytics", "Health & Safety" ], "regions": [ "United Kingdom" ], "category_urls": [ "https://undersrvd.com/opportunities/category/healthtech", "https://undersrvd.com/opportunities/category/nhs", "https://undersrvd.com/opportunities/category/health-and-social-care", "https://undersrvd.com/opportunities/category/medtech", "https://undersrvd.com/opportunities/category/data-and-analytics", "https://undersrvd.com/opportunities/category/health-and-safety" ], "region_urls": [ "https://undersrvd.com/opportunities/region/united-kingdom" ], "problem_statement": "Patients with vague, persistent or escalating symptoms can re-present multiple times without crossing a single-condition urgent-referral threshold. Clinical records contain the encounters, but the unresolved diagnostic story may be distributed across consultations, clinicians, tests and referrals, making it harder to notice repeated presentations and close the loop on uncertainty.\n\nOperational consequences:\nNHS England introduced Jess’s Rule to encourage teams to rethink after a third presentation with the same or escalating symptoms. Missed escalation can contribute to delayed diagnosis of cancer or other serious illness, while manual recall and ad-hoc searches add cognitive and administrative burden to already pressured practices.", "audience": "Primary users are GP practices, PCNs and ICB primary-care teams responsible for diagnostic safety and cancer pathways. Day-to-day users include GPs, advanced practitioners, care coordinators and practice clinical-safety leads. Patients with unresolved symptoms are the protected end users.\n\nBuyer and user context:\nThe economic buyer is likely an ICB, PCN federation or large practice group rather than an individual clinician. Any product must integrate with existing GP systems, preserve clinical judgement and meet NHS clinical-safety, information-governance and procurement requirements. It should flag unresolved patterns, not diagnose cancer autonomously.", "evidence_summary": "NHS England’s Jess’s Rule formalises a 'three strikes and rethink' prompt after repeated presentations and is motivated by the risk of missed serious illness. NHS guidance on direct-access diagnostics states that patients with symptoms below urgent-cancer thresholds still need routes to testing. Innovate UK explicitly seeks technology that improves early identification and access while reducing service pressure. C the Signs proves there is an NHS software budget for earlier cancer diagnosis and publicly lists annual pricing by patient population.\n\nEvidence interpretation:\nThe evidence supports a workflow and patient-safety problem, but direct competition means the proposition must not simply replicate cancer risk assessment. The strongest product is a cross-condition unresolved-case tracker that can invoke existing cancer tools/pathways when appropriate and prove that diagnostic loops are closed.", "demand_signal": "NHS England has created a national behavioural rule and diagnostic-access guidance, indicating a system-wide need rather than a local anecdote. C the Signs’ G-Cloud listing and other referral/monitoring products demonstrate that NHS buyers procure population-based digital tools in this workflow.\n\nValidation approach:\nRun structured discovery with 5 PCNs and 2 ICB cancer/diagnostics teams. Retrospectively identify patients with 3+ presentations for similar unresolved symptoms and measure how reliably existing systems surface them. A prototype should reduce manual case-finding time and identify clinically reviewed cases that otherwise would not have been prompted.", "competition_signal": "C the Signs is the clearest adjacent competitor, supporting cancer risk assessment and referral and publicly priced at roughly £0.20–£0.33 per patient/year. NHS practices also have search/reporting functionality in existing clinical systems, and specialist referral/monitoring platforms can track pathways once a patient enters them.\n\nPotential defensibility:\nDefensibility would come from longitudinal episode linking, configurable 'unresolved diagnostic story' logic, closed-loop test/referral tracking, explainable provenance from the GP record and integrations that complement rather than replace existing cancer-decision tools. Clinical validation data and safety-case evidence could become a substantial barrier to entry.", "suggested_solution": "A primary-care safety-net service that continuously identifies repeated or unresolved symptom episodes, links related consultations/tests/referrals and prompts an appropriate human review when a configured threshold is reached. It displays the timeline, outstanding actions and existing pathway options but does not make an autonomous cancer diagnosis.\n\nIntended outcome:\nMake repeated unresolved presentations difficult to lose in the record, support Jess’s Rule consistently and shorten avoidable diagnostic delay without flooding clinicians with low-value alerts.", "monetisation_angle": "Pricing classification:\nProxy based — medium confidence.\n\nIndicative pricing:\nC the Signs publicly lists £0.20–£0.33 per patient per year, providing a useful direct category benchmark. A narrower safety-net module would need to prove either similar population-based economics or clear workflow savings; an initial test could price at £0.10–£0.25 per registered patient/year or a fixed paid PCN pilot, with integration and clinical-safety work priced separately.\n- Paid PCN safety-net pilot: £5,000–£12,500 for 8–12 weeks\n\nEvidence basis:\nG-Cloud — C the Signs AI Cancer Prediction Platform and pricing (Linked pricing/rate page; no exact comparable price was extracted for this review) is the closest verified adjacent anchor used here. Its buyer, duration and scope are not assumed to be identical; implementation is separated where the opportunity requires integration, assurance or managed delivery.\n\nCommercial test:\nAsk one accountable NHS, council, employer, school-system or care-service budget owner to fund a paid test of Persistent-Symptom Diagnostic Safety-Net for Primary Care lasting 8–12 weeks, using an opening price of £5,000–£12,500 and covering two operational teams and 50 representative referrals, cases or employees. Paid scope: A primary-care safety-net service that continuously identifies repeated or unresolved symptom episodes, links related consultations/tests/referrals and prompts an appropriate human review when a configured threshold is reached. Charge by service, organisation, enrolled person or managed cohort and compare the fee with current referral, case-coordination, absence-management and specialist-support effort. Measure time to action, safe escalation, case completion, avoidable hand-offs, staff hours and sustained return/retention. Continue only if time to appropriate action improves by at least 20%, no safety escalation is missed and the budget owner elects to continue. Stop or reprice if clinical or safeguarding quality falls, coordination effort rises or the buyer will not fund the next cohort.", "underserved_score": 79, "score_rationale": "High-confidence problem with strong NHS policy evidence and an obvious patient-safety consequence. The commercial score is kept below 80 because C the Signs and incumbent clinical systems already occupy adjacent territory, so the unserved gap must be proven as longitudinal unresolved-case safety-netting rather than cancer prediction.\n\nWhat would change the score:\nRaise into the mid-80s if PCNs show substantial manual work or missed cases after implementing Jess’s Rule and pay for automated case finding. Reduce below 65 if C the Signs, EMIS/SystmOne tooling or ICB population-health platforms already provide reliable repeated-presentation and closed-loop diagnostic tracking.", "score_scale": { "min": 0, "max": 100 }, "sources": [ { "name": "Innovate UK — Accelerated Cancer Diagnosis competition", "url": "https://apply-for-innovation-funding.service.gov.uk/competition/2527/overview/d48f61f8-2bd5-4067-9c05-29dd08487623", "publisher": "apply-for-innovation-funding.service.gov.uk", "source_type": null, "date": null, "note": null }, { "name": "NHS England — Jess’s Rule: Three strikes and we rethink", "url": "https://www.england.nhs.uk/long-read/jesss-rule-three-strikes-and-we-rethink/", "publisher": "england.nhs.uk", "source_type": null, "date": null, "note": null }, { "name": "NHS England — GP direct access to diagnostic services", "url": "https://www.england.nhs.uk/long-read/urgent-gp-direct-access-to-diagnostic-services-for-people-with-symptoms-not-meeting-the-threshold-for-an-urgent-suspected-cancer-referral/", "publisher": "england.nhs.uk", "source_type": null, "date": null, "note": null }, { "name": "NHS England — Primary Care Patient Safety Strategy", "url": "https://www.england.nhs.uk/long-read/primary-care-patient-safety-strategy/", "publisher": "england.nhs.uk", "source_type": null, "date": null, "note": null }, { "name": "G-Cloud — C the Signs AI Cancer Prediction Platform and pricing", "url": "https://www.applytosupply.digitalmarketplace.service.gov.uk/g-cloud/services/369091500655811", "publisher": "applytosupply.digitalmarketplace.service.gov.uk", "source_type": null, "date": null, "note": null }, { "name": "C the Signs — G-Cloud pricing document", "url": "https://assets.applytosupply.digitalmarketplace.service.gov.uk/g-cloud-14/documents/718982/369091500655811-pricing-document-2024-05-07-1252.pdf", "publisher": "assets.applytosupply.digitalmarketplace.service.gov.uk", "source_type": null, "date": null, "note": null } ], "related_opportunities": [ { "title": "Regional Social Economy Intelligence Platform", "slug": "regional-social-economy-intelligence-platform", "url": "https://undersrvd.com/opportunities/regional-social-economy-intelligence-platform", "api_url": "https://undersrvd.com/api/public/opportunities/regional-social-economy-intelligence-platform.json", "underserved_score": 92, "categories": [ "GovTech", "Data & Analytics", "Economic Development" ], "regions": [ "United Kingdom" ] }, { "title": "Critical Infrastructure Dependency and Blast-Radius Mapper", "slug": "critical-infrastructure-dependency-blast-radius-mapper", "url": "https://undersrvd.com/opportunities/critical-infrastructure-dependency-blast-radius-mapper", "api_url": "https://undersrvd.com/api/public/opportunities/critical-infrastructure-dependency-blast-radius-mapper.json", "underserved_score": 91, "categories": [ "Infrastructure", "Data & Analytics", "GovTech", "Safety & Security", "Energy & Utilities" ], "regions": [ "United Kingdom", "Greater Manchester", "North West England" ] }, { "title": "Drainage-Ready Planning and Development Copilot", "slug": "drainage-ready-planning-development-copilot", "url": "https://undersrvd.com/opportunities/drainage-ready-planning-development-copilot", "api_url": "https://undersrvd.com/api/public/opportunities/drainage-ready-planning-development-copilot.json", "underserved_score": 91, "categories": [ "ClimateTech", "PropTech", "GovTech", "Data & Analytics", "Property & Built Environment" ], "regions": [ "United Kingdom" ] }, { "title": "Texas Data-Centre Audit Submission and Evidence Workspace", "slug": "texas-data-centre-audit-submission-and-evidence-workspace", "url": "https://undersrvd.com/opportunities/texas-data-centre-audit-submission-and-evidence-workspace", "api_url": "https://undersrvd.com/api/public/opportunities/texas-data-centre-audit-submission-and-evidence-workspace.json", "underserved_score": 91, "categories": [ "Compliance", "Energy & Utilities", "B2B SaaS", "Data & Analytics" ], "regions": [ "Texas", "United States" ] }, { "title": "BNG 30-Year Stewardship Ledger and Local Exchange", "slug": "bng-30-year-stewardship-ledger-local-exchange", "url": "https://undersrvd.com/opportunities/bng-30-year-stewardship-ledger-local-exchange", "api_url": "https://undersrvd.com/api/public/opportunities/bng-30-year-stewardship-ledger-local-exchange.json", "underserved_score": 90, "categories": [ "ClimateTech", "RegTech", "GovTech", "Marketplaces", "Data & Analytics" ], "regions": [ "United Kingdom" ] }, { "title": "Local Government Transition Compliance & Service Continuity Platform", "slug": "local-government-transition-compliance-service-continuity-platform", "url": "https://undersrvd.com/opportunities/local-government-transition-compliance-service-continuity-platform", "api_url": "https://undersrvd.com/api/public/opportunities/local-government-transition-compliance-service-continuity-platform.json", "underserved_score": 90, "categories": [ "GovTech", "Compliance", "Operations", "HealthTech" ], "regions": [ "United Kingdom" ] } ], "license": "https://undersrvd.com/data-license" }